Early Cellular Changes in the Ascending Aorta and Myocardium in a Swine Model of Metabolic Syndrome

PloS One
Rabya SarafRobina Matyal

Abstract

Metabolic syndrome is associated with pathological remodeling of the heart and adjacent vessels. The early biochemical and cellular changes underlying the vascular damage are not fully understood. In this study, we sought to establish the nature, extent, and initial timeline of cytochemical derangements underlying reduced ventriculo-arterial compliance in a swine model of metabolic syndrome. Yorkshire swine (n = 8 per group) were fed a normal diet (ND) or a high-cholesterol (HCD) for 12 weeks. Myocardial function and blood flow was assessed before harvesting the heart. Immuno-blotting and immuno-histochemical staining were used to assess the cellular changes in the myocardium, ascending aorta and left anterior descending artery (LAD). There was significant increase in body mass index, blood glucose and mean arterial pressures (p = 0.002, p = 0.001 and p = 0.024 respectively) in HCD group. At the cellular level there was significant increase in anti-apoptotic factors p-Akt (p = 0.007 and p = 0.002) and Bcl-xL (p = 0.05 and p = 0.01) in the HCD aorta and myocardium, respectively. Pro-fibrotic markers TGF-β (p = 0.01), pSmad1/5 (p = 0.03) and MMP-9 (p = 0.005) were significantly increased in the HCD aorta. The levels of pro-apopto...Continue Reading

References

Dec 1, 1990·Annals of Medicine·M I UusitupaK E Airaksinen
Nov 1, 1995·Diabetes·S M Baumgartner-ParzerW Waldhäusl
Apr 14, 1995·Mechanisms of Ageing and Development·J Marín
Jun 29, 2000·Journal of Hypertension·N S DhallaT Netticadan
Nov 14, 2000·Circulation Research·H Cai, D G Harrison
Mar 27, 2001·Journal of the American College of Cardiology·A M Dart, B A Kingwell
Apr 16, 2003·Circulation·Ronald M A HenryUNKNOWN Hoorn Study
Oct 11, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Yuji MatsuzawaIichiro Shimomura
Nov 25, 2003·Diabetes·J Robinson SingletonEva L Feldman
Oct 23, 2004·American Journal of Physiology. Heart and Circulatory Physiology·Ilan HayMathew S Maurer
Feb 12, 2005·Nephrology·Wansheng WangHui Y Lan
Feb 26, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·Susan J ZiemanDavid A Kass
Jan 3, 2006·Journal of the American College of Cardiology·Michel E SafarAthanase Benetos
Feb 8, 2006·Circulation·Francesco U S Mattace-RasoJacqueline C M Witteman
Feb 21, 2006·Journal of the American College of Cardiology·Juan Asbun, Francisco J Villarreal
May 10, 2006·Diabetic Medicine : a Journal of the British Diabetic Association·K G M M AlbertiJ Shaw
Sep 10, 2010·Journal of Molecular and Cellular Cardiology·Michael P RobichFrank W Sellke
Oct 30, 2010·Circulation Research·Ferdinando Giacco, Michael Brownlee
Jan 29, 2011·Drug Discovery Today. Disease Mechanisms·Pavan K BattiproluJoseph A Hill
Feb 26, 2011·Journal of Pharmacology & Pharmacotherapeutics·Carol KilkennyDouglas G Altman
Sep 18, 2013·American Journal of Physiology. Heart and Circulatory Physiology·Sergey I Dikalov, Zoltan Ungvari
Sep 23, 2014·Atherosclerosis·Huige LiUlrich Förstermann
Dec 3, 2014·Atherosclerosis·Snigdha JainJulio A Chirinos

❮ Previous
Next ❯

Methods Mentioned

BETA
sedation
blood draws
X-ray
Assay

Software Mentioned

ImageJ
Zeiss
ARRIVE
Statistical Package for Social Sciences

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.